Health Affairs October 21, 2020
Kevin N. Griffith Melinda B. Buntin

Editor’s Note

This post is part of a Health Affairs Blog short series, “Higher Health Care Value Post COVID-19.” The series examines opportunities to create a research and policy agenda using the changes wrought by COVID-19 to help create a better health care system in its aftermath. The posts in the series were completed with support for the authors from the Research Consortium for Health Care Value Assessment, a partnership between Altarum and VBID Health, through a grant from the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA extended complete independence to Altarum to select researchers and specific topics. Health Affairs retained review and editing rights.

The human cost of COVID-19 has been enormous, claiming the lives of more than 209,000 US citizens through October 15, 2020. The pandemic’s...

Today's Sponsors

ZeOmega
holon
ClearDATA

Today's Sponsors

Augmedix
ZeOmega

Today's Sponsor

Augmedix

2020-10-21T17:36:53-04:00